论文部分内容阅读
本月全球药品研发进展取得成效的药物有24个,比上月增加了3个,获得新药注册的药品数量大幅反弹,而进入III期临床研究阶段的药品数量则比上月减少6个。
There were 24 drugs that made progress in drug research and development globally this month, an increase of 3 last month. The number of drug registrations for new drugs rebounded sharply, while the number of drugs entering Phase III clinical research fell by 6 from the previous month.